People's Justice

New York · Claims for harm linked to Dupixent

Claims for harm linked to Dupixent in New York

See If You Qualify

Free · No obligation · About 2 minutes

Filing deadline3 years from discovery of injury; medical monitoring available pre-diagnosisCPLR § 214

Deadlines vary with the facts of each case. A lawyer can confirm yours.

Updated

01 · Your filing deadline

What is the deadline in New York?

New York: 3 years for personal injury (CPLR § 214). Discovery rule applies. New York also recognizes medical monitoring claims, allowing plaintiffs to seek monitoring costs before a cancer diagnosis is confirmed. A lawyer can confirm yours.

3 years from discovery of injury; medical monitoring available pre-diagnosis

Source: CPLR § 214

Deadlines vary; a lawyer can confirm yours. An older diagnosis or a past filing window does not, by itself, establish whether you have a claim.

Woman on the phone on her sofa, smiling
A lawyer can check which filing rules apply to your circumstances.

02 · Where cases are heard

Where would my case be heard?

New York is a critical jurisdiction for Dupixent litigation given Regeneron's corporate headquarters in Tarrytown, Westchester County. This establishes strong personal jurisdiction and creates potential venue advantages for plaintiffs filing in the Southern District of New York. The state's world-class dermatology and oncology institutions — including Memorial Sloan Kettering, NYU Langone, and Columbia — provide robust diagnostic infrastructure for CTCL identification.

Regeneron Pharmaceuticals is headquartered in Tarrytown, NY (Westchester County), within the Southern District of New York. This provides strong personal jurisdiction and makes SDNY a natural venue for Dupixent CTCL cases. The Southern District has extensive experience with complex pharmaceutical MDLs. New York state courts also offer coordination through the NYCAL (New York City Asbestos Litigation) model for mass tort management. New York does not cap compensatory damages in product liability cases. The state's recognition of medical monitoring claims allows at-risk Dupixent users to seek monitoring costs even before a CTCL diagnosis.

How this works nationally

For the overall process and updates, read the Claims for harm linked to Dupixent overview. This page covers the local information available for New York.

What happens when I check?

You answer a few short questions about what happened. If you send them, your answers are kept on file. If a participating law firm takes these cases, it may contact you. People's Justice is not a law firm.

Live in New York? Read what applies in your state.

Register your interest. If a participating law firm takes these cases, it may contact you.

Register your interest

Sources

  1. CPLR § 214